High prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care

Diabetes mellitus (DM), especially type 2 diabetes mellitus (T2DM), has been identified as a risk factor for poor outcomes in patients with COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)(1), although the underlying pathophysiology is not understood(2). Anecdotally, a high incidence of ketoacidosis has been observed in patients admitted to hospital with COVID-19 but currently there remains a lack of peer-reviewed studies addressing this(3).
Source: Diabetes Research and Clinical Practice - Category: Endocrinology Authors: Source Type: research